| |
| Device | Edwards SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra Adaptive Prestent |
| Generic Name | Pulmonary valve prosthesis percutaneously delivered |
| Applicant | Edwards Lifesciences, LLC One Edwards Way Irvine, CA 92614 |
| PMA Number | P200015 |
| Supplement Number | S011 |
| Date Received | 06/21/2021 |
| Decision Date | 12/16/2021 |
| Product Code |
NPV |
| Docket Number | 21M-1325 |
| Notice Date | 12/17/2021 |
| Advisory Committee |
Cardiovascular |
| Clinical Trials | NCT03130777
|
| Supplement Type | Panel Track |
| Supplement Reason | Change Design/Components/Specifications/Material |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for the Edwards SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra Adaptive Prestent. The device is indicated for use in the management of pediatric and adult patients with severe pulmonary regurgitation as measured by echocardiography who have a native or surgically-repaired right ventricular outflow tract and are clinically indicated for pulmonary valve replacement. |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling Labeling Part 2 |
| Post-Approval Study | Show Report Schedule and Study Progress |